A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04667104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: JNJ-73763989
DRUG: Tenofovir disoproxil
DRUG: Tenofovir alafenamide (TAF)
DRUG: Entecavir (ETV) monohydrate
DRUG: PegIFN-alpha2a

Sponsor

Janssen Research & Development, LLC